Edition:
United States

Falco Holdings Co Ltd (4671.T)

4671.T on Tokyo Stock Exchange

1,582JPY
24 Mar 2017
Change (% chg)

¥9 (+0.57%)
Prev Close
¥1,573
Open
¥1,570
Day's High
¥1,594
Day's Low
¥1,570
Volume
28,400
Avg. Vol
12,488
52-wk High
¥1,594
52-wk Low
¥1,281

Summary

Name Age Since Current Position

Kenjiro Hirasaki

63 2015 Chairman of the Board

Hiroharu Akazawa

71 2015 President, Chairman of Subsidiary, Representative Director

Tadashi Yasuda

55 2013 Manager of Strategy Operation Office, President of Subsidiary, Director

Nobumasa Matsubara

Manager of Pharma Business Office, Manager of Business Development Office, Assistant Manager of Clinical Business Office, President of Subsidiary, Director

Hiroshi Eguchi

2014 Executive Officer, Manager of Clinical Business Office

Masahiko Mori

2012 Executive Officer, Manager of Pharma Business Office

Seishu Takei

2013 Executive Officer, Manager of Operation Supervision Office

Biographies

Name Description

Kenjiro Hirasaki

Mr. Kenjiro Hirasaki was named Chairman of the Board in FALCO HOLDINGS Co., Ltd. effective June 24, 2015. He joined the former entity of the Company in August 1970. His previous titles include Senior Managing Director and Vice President in the Company.

Hiroharu Akazawa

Mr. Hiroharu Akazawa was named President and Representative Director in FALCO HOLDINGS Co., Ltd., as well as Chairman of the Board and Representative Director of a subsidiary, effective June 24, 2015. He joined the former entity of the Company in July 1962. He previously served as President in the Company.

Tadashi Yasuda

Mr. Tadashi Yasuda has been serving as Manager of Strategy Operation Office and Director in FALCO SD HOLDINGS Co., Ltd., as well as President and Representative Director in a subsidiary, since June 21, 2013. He joined the Company in February 1995. His previous titles include Director of Business Planning, Director of Accounting, Manager of Pharma Business Office, Chief Director of Business Planning, Managing Director, Chief Director of Business Development and Chief Director of Bio Business in the Company.

Nobumasa Matsubara

Hiroshi Eguchi

Masahiko Mori

Seishu Takei